[Deglycinamide9, Arginine8]-Vasopressin

[Deglycinamide9, Arginine8]-Vasopressin is a Vasopressin (HY-B1811) analog. [Deglycinamide9, Arginine8]-Vasopressin induces platelet aggregation. [Deglycinamide9, Arginine8]-Vasopressin has hemostatic effect[1].

Product Specifications

CAS Number

[37552-33-3]

UNSPSC

12352209

Hazard Statement

H332

Target

Endogenous Metabolite

Type

Peptides

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/deglycinamide9-arginine8-vasopressin.html

Solubility

10 mM in DMSO

Smiles

O=C([C@H]1NC([C@@H](NC([C@@H](NC([C@](NC([C@H](CC2=CC=C(O)C=C2)NC([C@@H](N)CSSC1)=O)=O)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N4[C@@H](CCC4)C(N[C@H](C(O)=O)CCCNC(N)=N)=O

Molecular Formula

C44H61N13O12S2

Molecular Weight

1028.17

Precautions

P261-P271-P304+P340

References & Citations

[1]Golubeva MG, et, al. Correction of changes in ADP-induced platelet aggregation with vasopressin analogue desglycinamide-arginine-vasopressin. Bull Exp Biol Med. 2005 Aug;140 (2) :162-4.